A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work. ...more

November 16, 2009

The Greater Tampa Chamber of Commerce named Robert Rohrlack Jr. as its new president and CEO. ...more

March 26, 2009

Swiss pharmaceutical giant Roche agreed Thursday to pay $46.8 billion in cash to buy the 44 percent of California-based biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle between the companies. ...more

March 13, 2009

Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in a deal that gives Merck key new businesses, access to a promising pipeline of new products and the chance to cut costs by $3.5 billion more per year, including eliminating about 16,000 jobs. ...more

March 10, 2009

For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, a study released Thursday by the vaccine's maker said. ...more

November 14, 2008

Diana Levine went to a medical clinic with a severe migraine headache. She wound up with gangrene and an amputated forearm, the victim of a rare side effect from a popular anti-nausea drug, Phenergan. ...more

November 4, 2008

Two HIV drugs approved last year for patients who have developed resistance to older drugs also work well with new patients, and with fewer troubling side effects than a widely used regimen, according to the drugs' manufacturers. ...more

October 27, 2008

A vaccine against rotavirus, the leading cause of diarrhea in infants, has led to a dramatic drop in hospitalization and emergency room visits since it came on the market two years ago, doctors reported Saturday. ...more

October 27, 2008

One in four teen girls have rolled up their sleeves for the relatively new vaccine against a virus that causes cervical cancer, federal health officials said Thursday. ...more

October 10, 2008

St. Joseph's Hospital has embarked on a five-year contract with Moffitt Cancer Center to conduct specific genetic testing of tumors of individual patients in hopes of developing better cancer treatments. ...more

September 16, 2008